North America ECG Telemetry Device Market

Market Introduction

ECG device monitors and record electrical activity of the heart and the device detects and picks up electrical impulses generated by the polarization and depolarization of cardiac tissue and translate them into waveform. This helps physician or cardiologist to diagnose cardiac abnormalities as well as size and position of chambers.

Thus, a surge in geriatric population is expected to create a significant demand for ECG telemetry device in the coming years, which is further anticipated to drive the ECG telemetry device market.

As the COVID-19 pandemic continues to unfold, medical device companies are finding difficulties in managing their operations. Many companies offering products for cardiac monitoring have their business operations in the United states and business are adversely being affected by the effects of a widespread outbreak of COVID-19. This has disrupted and restricted company’s ability to distribute products, as well as temporary closures of our facilities or the facilities of our suppliers or customers. Moreover, market players also witnessed disruption in their business operations since March 2020, as US healthcare authorities framed policies about elective cardiac surgeries. Also, to free-up limited space for people being treated for the virus, hospitals have postponed, or cancelled. However, demand for vital sign monitoring devices in the region had substantial impact on the adoption of ECG telemetry. Though, there was disruption in distribution, demand for such products had marginal positive impact on the North America ECG telemetry devices market.

North America ECG Telemetry Device Strategic Insights

Strategic insights for the North America ECG Telemetry Device provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

North America ECG Telemetry Device Report Scope

North America ECG Telemetry Device Regional Insights

The geographic scope of the North America ECG Telemetry Device refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

The ECG telemetry device market in North America is expected to grow from US$ 1,185.3 million in 2021 to US$ 2,075.2 million by 2028; it is estimated to grow at a CAGR of 8.3% from 2021 to 2028. The developing countries are focusing on bringing advancements in their healthcare infrastructure and services. For instance, in March 2020, Biotelemetry, Inc. expanded its mobile cardiac outpatient telemetry monitoring program to COVID-19 patients in various institutions in the US to monitor QT prolongation associated with hydroxychloroquine and azithromycin medication. Thus, the ECG telemetry devices market players are leveraging the opportunities offered by developing countries to enter the market with cost-effective products, which would drive their growth during the forecast period.

Key Market Segments

In terms of product, the resting ECG devices segment accounted for the largest share of the North America ECG telemetry device market in 2020. In terms of end user, the hospitals segment held a larger market share of the ECG telemetry device market in 2020.

Major Sources and Companies Listed

A few major primary and secondary sources referred to for preparing this report on the ECG telemetry device market in North America are company websites, annual reports, financial reports, national government documents, and statistical database, among others. Major companies listed in the report are Cardiac Science Corporation

,

,

,

,

,

,

,

,

,

Reasons to buy report

• To understand the North America ECG telemetry device market landscape and identify market segments that are most likely to guarantee a strong return
• Stay ahead of the race by comprehending the ever-changing competitive landscape for North America ECG telemetry device market
• Efficiently plan M&A and partnership deals in North America ECG telemetry device market by identifying market segments with the most promising probable sales
• Helps to take knowledgeable business decisions from perceptive and comprehensive analysis of market performance of various segment form North America ECG telemetry device market
• Obtain market revenue forecast for market by various segments from 2021-2028 in North America region.

NORTH AMERICA ECG TELEMETRY DEVICE MARKET SEGMENTATION

By Product

• Resting ECG Devices
• Stress ECG Devices
• Others

By End User

• Home Healthcare
• Hospitals

By Country

• North America
  • US
  • Canada
  • Mexico

Companies Mentioned

1. Cardiac Science Corporation
2. CompuMed Inc.
3. GE Healthcare Inc.
4. Medtronic Inc.
5. Mindray Medical International Ltd.
6. Nihon Kohden Corporation
7. Philips Healthcare
8. ScottCare Corporation
9. Dragger
10. Welch Allyn Inc